▶ 調査レポート

世界の血管内皮増殖因子(VEGF)抗体市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の血管内皮増殖因子(VEGF)抗体市場 2021:企業別、地域別、種類・用途別 / Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-111D11604資料のイメージです。• レポートコード:GIR-111D11604
• 出版社/出版日:GlobalInfoResearch / 2021年10月
• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥459,360 (USD3,480)▷ お問い合わせ
  Multi User¥689,040 (USD5,220)▷ お問い合わせ
  Corporate User¥918,720 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、血管内皮増殖因子(VEGF)抗体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。血管内皮増殖因子(VEGF)抗体の種類別市場規模(ベバシズマブ、ラニビズマブ、アフリベルセプト、その他)、用途別市場規模(病院、専門クリニック、外来手術センター、がん研究所、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・血管内皮増殖因子(VEGF)抗体の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Roche、Novartis、Sanofi、Regeneron、Bayer、AstraZeneca、Pfizer、Merck、Eli Lilly、GlaxoSmithKline、Bristol-Myer Squibb、Boehringer Ingelheim、Abcam Plc
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ベバシズマブ、ラニビズマブ、アフリベルセプト、その他
・用途別分析2016年-2026年:病院、専門クリニック、外来手術センター、がん研究所、その他
・血管内皮増殖因子(VEGF)抗体の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・血管内皮増殖因子(VEGF)抗体のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・血管内皮増殖因子(VEGF)抗体のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・血管内皮増殖因子(VEGF)抗体の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・血管内皮増殖因子(VEGF)抗体の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Vascular Endothelial Growth Factor (VEGF) Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Vascular Endothelial Growth Factor (VEGF) Antibodies size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Vascular Endothelial Growth Factor (VEGF) Antibodies market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Vascular Endothelial Growth Factor (VEGF) Antibodies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Bevacizumab
Ranibizumab
Aflibercept
Others

Market segment by Application can be divided into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
Others

The key market players for global Vascular Endothelial Growth Factor (VEGF) Antibodies market are listed below:
Roche
Novartis
Sanofi
Regeneron
Bayer
AstraZeneca
Pfizer
Merck
Eli Lilly
GlaxoSmithKline
Bristol-Myer Squibb
Boehringer Ingelheim
Abcam Plc

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Vascular Endothelial Growth Factor (VEGF) Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vascular Endothelial Growth Factor (VEGF) Antibodies, with price, sales, revenue and global market share of Vascular Endothelial Growth Factor (VEGF) Antibodies in 2018 and 2019.
Chapter 3, the Vascular Endothelial Growth Factor (VEGF) Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vascular Endothelial Growth Factor (VEGF) Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vascular Endothelial Growth Factor (VEGF) Antibodies market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Vascular Endothelial Growth Factor (VEGF) Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bevacizumab
1.2.3 Ranibizumab
1.2.4 Aflibercept
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Cancer Research Institutes
1.3.6 Others
1.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size & Forecast
1.4.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Value (2016-2026))
1.4.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume (2016-2026)
1.4.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2016-2026) & (US$/Unit)
1.5 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Production Capacity Analysis
1.5.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Total Production Capacity (2016-2026)
1.5.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Market Drivers
1.6.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Market Restraints
1.6.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.1.4 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.2.4 Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.3.4 Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Regeneron
2.4.1 Regeneron Details
2.4.2 Regeneron Major Business
2.4.3 Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.4.4 Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.5.4 Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.6.4 AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.7.4 Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.8.4 Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.9.4 Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.10.4 GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Bristol-Myer Squibb
2.11.1 Bristol-Myer Squibb Details
2.11.2 Bristol-Myer Squibb Major Business
2.11.3 Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.11.4 Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Boehringer Ingelheim
2.12.1 Boehringer Ingelheim Details
2.12.2 Boehringer Ingelheim Major Business
2.12.3 Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.12.4 Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Abcam Plc
2.13.1 Abcam Plc Details
2.13.2 Abcam Plc Major Business
2.13.3 Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
2.13.4 Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Manufacturer
3.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vascular Endothelial Growth Factor (VEGF) Antibodies
3.4 Market Concentration Rate
3.4.1 Top 3 Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturer Market Share
3.4.2 Top 6 Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturer Market Share
3.5 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vascular Endothelial Growth Factor (VEGF) Antibodies Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Region
4.1.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Region (2016-2026)
4.1.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2016-2026)
4.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026)
4.3 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026)
4.4 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026)
4.5 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026)
4.6 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Type (2016-2026)
5.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2016-2026)
5.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Application (2016-2026)
6.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2016-2026)
6.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2026)
7.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2026)
7.3 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
7.3.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Country (2016-2026)
7.3.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2026)
8.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2026)
8.3 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
8.3.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Country (2016-2026)
8.3.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2026)
9.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2026)
9.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Region
9.3.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2026)
10.2 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2026)
10.3 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
10.3.1 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Country (2016-2026)
10.3.2 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2026)
11.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2026)
11.3 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
11.3.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Typical Distributors
12.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 6. Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 10. Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 14. Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Regeneron Basic Information, Manufacturing Base and Competitors
Table 16. Regeneron Major Business
Table 17. Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 18. Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 22. Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 26. AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 30. Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 34. Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 38. Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 40. GlaxoSmithKline Major Business
Table 41. GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 42. GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Bristol-Myer Squibb Basic Information, Manufacturing Base and Competitors
Table 44. Bristol-Myer Squibb Major Business
Table 45. Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 46. Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 48. Boehringer Ingelheim Major Business
Table 49. Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 50. Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Abcam Plc Basic Information, Manufacturing Base and Competitors
Table 52. Abcam Plc Major Business
Table 53. Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Product and Services
Table 54. Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Vascular Endothelial Growth Factor (VEGF) Antibodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Vascular Endothelial Growth Factor (VEGF) Antibodies Production Site of Key Manufacturer
Table 60. Vascular Endothelial Growth Factor (VEGF) Antibodies New Entrant and Capacity Expansion Plans
Table 61. Vascular Endothelial Growth Factor (VEGF) Antibodies Mergers & Acquisitions in the Past Five Years
Table 62. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2016-2021e) & (K Units)
Table 63. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2021-2026) & (K Units)
Table 64. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2021e) & (K Units)
Table 67. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (K Units)
Table 68. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2016-2021e) & (US$/Unit)
Table 71. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2021-2026) & (US$/Unit)
Table 72. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2021e) & (K Units)
Table 73. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (K Units)
Table 74. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2016-2021e) & (US$/Unit)
Table 77. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2021-2026) & (US$/Unit)
Table 78. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021e) & (K Units)
Table 79. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (K Units)
Table 80. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2021e) & (K Units)
Table 83. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (K Units)
Table 84. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2021e) & (K Units)
Table 85. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (K Units)
Table 86. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021e) & (K Units)
Table 87. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (K Units)
Table 88. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2021e) & (K Units)
Table 91. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (K Units)
Table 92. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2021e) & (K Units)
Table 93. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (K Units)
Table 94. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2016-2021e) & (K Units)
Table 95. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2021-2026) & (K Units)
Table 96. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2021e) & (K Units)
Table 99. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (K Units)
Table 100. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2021e) & (K Units)
Table 101. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (K Units)
Table 102. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021e) & (K Units)
Table 103. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (K Units)
Table 104. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2021e) & (K Units)
Table 107. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (K Units)
Table 108. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2021e) & (K Units)
Table 109. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (K Units)
Table 110. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2016-2021e) & (K Units)
Table 111. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (K Units)
Table 112. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2016-2021e) & (K Units)
Table 115. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (K Units)
Table 116. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2016-2021e) & (K Units)
Table 117. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (K Units)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Vascular Endothelial Growth Factor (VEGF) Antibodies Typical Distributors
Table 121. Vascular Endothelial Growth Factor (VEGF) Antibodies Typical Customers
List of Figures
Figure 1. Vascular Endothelial Growth Factor (VEGF) Antibodies Picture
Figure 2. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type in 2020
Figure 3. Bevacizumab
Figure 4. Ranibizumab
Figure 5. Aflibercept
Figure 6. Others
Figure 7. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application in 2020
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Cancer Research Institutes
Figure 12. Others
Figure 13. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (2016-2026) & (K Units)
Figure 16. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2016-2026) & (US$/Unit)
Figure 17. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Production Capacity (2016-2026) & (K Units)
Figure 18. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Drivers
Figure 20. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Restraints
Figure 21. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Trends
Figure 22. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Manufacturer in 2020
Figure 23. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Manufacturer in 2020
Figure 24. Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Vascular Endothelial Growth Factor (VEGF) Antibodies Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2016-2026)
Figure 28. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region (2016-2026)
Figure 29. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026) & (USD Million)
Figure 30. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026) & (USD Million)
Figure 32. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2016-2026) & (USD Million)
Figure 34. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2016-2026)
Figure 35. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Type (2016-2026)
Figure 36. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2016-2026) & (US$/Unit)
Figure 37. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2016-2026)
Figure 38. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Application (2016-2026)
Figure 39. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2016-2026) & (US$/Unit)
Figure 40. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2016-2026)
Figure 41. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2016-2026)
Figure 42. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2016-2026)
Figure 43. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country (2016-2026)
Figure 44. United States Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2016-2026)
Figure 48. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2016-2026)
Figure 49. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2016-2026)
Figure 50. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country (2016-2026)
Figure 51. Germany Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Region (2016-2026)
Figure 60. China Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2016-2026)
Figure 67. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2016-2026)
Figure 68. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2016-2026)
Figure 69. South America Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source